PTCT PTC Therapeutics Inc

$78.47

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About PTC Therapeutics Inc

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. The company is headquartered in South Plainfield, New Jersey.

Website: https://www.ptcbio.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1070081
Address
100 CORPORATE COURT, SOUTH PLAINFIELD, NJ, US
Valuation
Market Cap
$3.74B
P/E Ratio
nan
PEG Ratio
0.81
Price to Book
1743.27
Performance
EPS
$-4.73
Dividend Yield
—
Profit Margin
-45.00%
ROE
-7740.00%
Technicals
50D MA
$50.51
200D MA
$42.12
52W High
$58.38
52W Low
$24.00
Fundamentals
Shares Outstanding
79M
Target Price
$64.64
Beta
0.58

PTCT EPS Estimates vs Actual

● Estimated
● Actual

PTCT News & Sentiment

Nov 18, 2025 • Motley Fool SOMEWHAT-BULLISH
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here's Why
A healthcare hedge fund just trimmed its biggest holding-right as the company posts a clinical and financial breakout year.
Nov 18, 2025 • Motley Fool SOMEWHAT-BULLISH
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally
A healthcare hedge fund just locked in gains on one of its biggest winners-here's what that move really signals.
Nov 04, 2025 • Zacks Commentary NEUTRAL
PTC Therapeutics ( PTCT ) Q3 Earnings and Revenues Top Estimates
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +116.81% and +20.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Travere Therapeutics ( TVTX ) Beats Q3 Earnings and Revenue Estimates
Travere (TVTX) delivered earnings and revenue surprises of +190.32% and +59.45%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 29, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Praxis Precision Medicines, Inc. ( PRAX ) Expected to Beat Earnings Estimates: Should You Buy?
Praxis Precision Medicines (PRAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 28, 2025 • Zacks Commentary SOMEWHAT-BULLISH
PTC Therapeutics ( PTCT ) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sentiment Snapshot

Average Sentiment Score:

0.126
50 articles with scored sentiment

Overall Sentiment:

Neutral

PTCT Reported Earnings

Aug 07, 2025
Jun 30, 2025 (Pre market)
0.23 Surprise
  • Reported EPS: $-0.83
  • Estimate: $-1.06
  • Whisper: —
  • Surprise %: 21.7%
May 06, 2025
Mar 31, 2025 (Pre market)
10.74 Surprise
  • Reported EPS: $10.04
  • Estimate: $-0.70
  • Whisper: —
  • Surprise %: 1524.1%
Feb 27, 2025
Dec 31, 2024 (Post market)
0.31 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.65
  • Whisper: —
  • Surprise %: 47.5%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $-1.39
  • Estimate: $-1.44
  • Whisper: —
  • Surprise %: 3.5%
Aug 08, 2024
Jun 30, 2024 (Post market)
-0.22 Surprise
  • Reported EPS: $-1.27
  • Estimate: $-1.05
  • Whisper: —
  • Surprise %: -20.9%
Apr 25, 2024
Mar 31, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $-1.20
  • Estimate: $-1.24
  • Whisper: —
  • Surprise %: 3.2%
Feb 29, 2024
Dec 31, 2023 (Post market)
-0.74 Surprise
  • Reported EPS: $-0.24
  • Estimate: $0.50
  • Whisper: —
  • Surprise %: -148.0%
Oct 26, 2023
Sep 30, 2023 (Post market)
-0.59 Surprise
  • Reported EPS: $-1.76
  • Estimate: $-1.17
  • Whisper: —
  • Surprise %: -50.4%
Aug 03, 2023
Jun 30, 2023 (Post market)
-0.95 Surprise
  • Reported EPS: $-2.66
  • Estimate: $-1.71
  • Whisper: —
  • Surprise %: -55.6%

Financials